11:51Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
12:28Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
08:47Evaluation of Cardiac Contractility Modulation Therapy in 2D Human Stem Cell-Derived Cardiomyocytes
10:16Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 20, 2026

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
Published on: March 1, 2016
George Thomas1, Jiwon Kim1, Bruce B Lerman1
1Department of Medicine, Division of Cardiology, Cornell University Medical Center New York, US.
Cardiac resynchronization therapy (CRT) improves heart failure outcomes by synchronizing left ventricular (LV) contractions. Advances in patient selection, lead placement, and pacing strategies enhance CRT
12:28Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
Published on: June 2, 2023
08:13Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: